Koba, Taro <br/><br/>
Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for untreated non-squamous non-small-cell lung cancer.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  07 2018 
 - 111-117 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-018-3598-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cisplatin--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Induction Chemotherapy<br/>Kaplan-Meier Estimate<br/>Lung Neoplasms--drug therapy<br/>Maintenance Chemotherapy<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Pemetrexed--administration & dosage<br/>Progression-Free Survival